Trump and Kennedy Jr. Raise Concerns About Tylenol and Autism: A Scientific Review

Last September, President Trump and his Health and Human Services Secretary, Robert F. Kennedy Jr., publicly voiced concerns about a potential link between acetaminophen—the active ingredient in Tylenol—and autism. These statements sparked controversy and prompted scrutiny from the medical community, given the inconclusive nature of existing research. The administration announced intentions to update drug labeling and explore potential treatments, but the follow-through has been limited.

The Initial Claims

During a White House press conference, President Trump claimed that Tylenol use during pregnancy could be linked to autism, despite experts cautioning that studies on the matter were mixed and did not establish a direct causal relationship. Kennedy Jr. Echoed these concerns, asserting that he had reviewed numerous studies indicating a clear connection between the drug and neurodevelopmental disorders. He later reiterated this stance on Fox News, calling pregnant women protesting the administration by taking Tylenol “pathological.”

The FDA and Medical Community Response

The U.S. Food and Drug Administration (FDA) responded to the announcement by acknowledging that a causal relationship between prenatal acetaminophen use and neurological conditions had not been established. The Hill reported that Kennedy Jr. Later softened his stance, admitting there wasn’t “sufficient” evidence to support the claim. Major medical groups too pushed back, emphasizing that Tylenol remains the safest painkiller during pregnancy and warning that discouraging its use, even when medically advised, could be harmful.

Conflicting Research Findings

Scientific studies examining the potential link between acetaminophen use during pregnancy and autism or ADHD have yielded inconsistent results. Some studies have found an association, while others have not. Large-scale studies conducted in Japan and Sweden, which compared siblings, found no association between acetaminophen and autism. These sibling studies are designed to control for genetic and environmental factors, providing a more rigorous assessment.

The Taiwanese Study and its Complications

A new study conducted in Taiwan, published in JAMA Pediatrics, has added another layer of complexity to the debate. While the study initially mirrored the findings of the Swedish and Japanese studies—showing an association between acetaminophen use and neurological disorders that disappeared when analyzing siblings—it also revealed a peculiar anomaly. The researchers found that if an older sibling was exposed to acetaminophen during pregnancy, they were more likely to develop ADHD or autism than a younger, unexposed sibling. Conversely, if only the younger sibling was exposed, the risk decreased. This unexpected result casts doubt on the validity of using sibling studies to assess the link, as the siblings did not act as reliable controls for each other.

Ongoing Uncertainty and Unfulfilled Promises

As of March 9, 2026, the science remains inconclusive regarding a causal link between acetaminophen and autism. Several promises made by the Trump administration following the initial announcement have not been fully realized. The FDA has not yet contacted Kenvue, the maker of Tylenol, regarding a proposed label change to indicate potential risks during pregnancy. A planned nationwide public-service campaign to inform families about the alleged dangers of prenatal acetaminophen use has not been launched.

Key Takeaways

• The link between Tylenol (acetaminophen) and autism remains scientifically unproven.
• Initial claims made by President Trump and Robert F. Kennedy Jr. Were met with skepticism from the medical community.
• Research findings are mixed, with some studies showing an association and others finding no link.
• A recent Taiwanese study introduced a confounding factor, questioning the reliability of sibling studies.
• Promises made by the administration to update drug labeling and launch a public awareness campaign have largely gone unfulfilled.